Non‐canonical cMet regulation by vimentin mediates Plk1 inhibitor–induced apoptosis

To address the need for improved systemic therapy for non–small‐cell lung cancer (NSCLC), we previously demonstrated that mesenchymal NSCLC was sensitive to polo‐like kinase (Plk1) inhibitors, but the mechanisms of resistance in epithelial NSCLC remain unknown. Here, we show that cMet was differenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Ratnakar, Peng, Shaohua, Viswanath, Pavitra, Sambandam, Vaishnavi, Shen, Li, Rao, Xiayu, Fang, Bingliang, Wang, Jing, Johnson, Faye M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505578/
https://www.ncbi.nlm.nih.gov/pubmed/31040125
http://dx.doi.org/10.15252/emmm.201809960

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505578/
https://www.ncbi.nlm.nih.gov/pubmed/31040125
http://dx.doi.org/10.15252/emmm.201809960

Ejemplares similares